Chromadex Corp CS (CDXC)
7.86 x 4 7.87 x 37
Post-market by (Cboe BZX)
7.87 -0.07 (-0.88%) 03/18/25 [NASDAQ]
7.86 x 4 7.87 x 37
Post-market 7.87 unch (unch) 16:00 ET
for Tue, Mar 18th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | 8,550 | -4,938 | -16,540 | -27,128 | -19,925 |
Depreciation Amortization | 814 | 1,028 | 1,055 | 1,115 | 1,114 |
Accounts receivable | -1,279 | 2,255 | -3,319 | -2,578 | -555 |
Accounts payable and accrued liabilities | -1,067 | 553 | -744 | 978 | -181 |
Other Working Capital | 3,134 | 4,562 | -6,318 | -5,010 | 347 |
Other Operating Activity | 1,957 | 3,657 | 10,768 | 8,460 | 8,600 |
Operating Cash Flow | $12,109 | $7,117 | $-15,098 | $-24,163 | $-10,600 |
Cash Flows From Investing Activities | |||||
PPE Investments | -143 | -143 | -334 | -409 | -124 |
Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -18 |
Other Investing Activity | 0 | 0 | 0 | 0 | -41 |
Investing Cash Flow | $-143 | $-143 | $-334 | $-409 | $-165 |
Cash Flows From Financing Activities | |||||
Common Stock Issued | 5,432 | N/A | 7,747 | 36,235 | 8,971 |
Other Financing Activity | -63 | -90 | -93 | -141 | -321 |
Financing Cash Flow | $5,369 | $-90 | $7,654 | $36,094 | $8,650 |
Beginning Cash Position | 27,325 | 20,441 | 28,219 | 16,697 | 18,812 |
End Cash Position | 44,660 | 27,325 | 20,441 | 28,219 | 16,697 |
Net Cash Flow | $17,335 | $6,884 | $-7,778 | $11,522 | $-2,115 |
Free Cash Flow | |||||
Operating Cash Flow | 12,109 | 7,117 | -15,098 | -24,163 | -10,600 |
Capital Expenditure | -163 | -148 | -334 | -409 | -124 |
Free Cash Flow | 11,946 | 6,969 | -15,432 | -24,572 | -10,724 |